Human genome: the hunt continues for 'malicious proteins'

July 8, 2010 by Michel Viatteau
This undated handout illustration shows the DNA double helix. Scientific advances of the past decade, such as the sequencing of the human genome, have opened up compelling new fields of research on the interaction of the body's 21,000 proteins, and the role they play in cancer and other diseases.

Scientific advances of the past decade, such as the sequencing of the human genome, have opened up compelling new fields of research on the interaction of the body's 21,000 proteins, and the role they play in cancer and other diseases.

This is the focus of the "International Interactome Initiative" ("Triple I") or as some researchers call it, "I Cubed," led by Canadian Benoit Coulombe, director of the and Proteomics Laboratory at the Institut de Recherches Cliniques de Montreal -- the Clinical Research Institute of Montreal.

"Through sequencing, we obtained a list of all the proteins in the human body. We know their sequence through the DNA that encodes them, but for a large number of them, we had never seen them before and never studied them," he said.

We know even less about how they interact and what the biological outcomes are.

Proteins act not individually, but in "complexes" or groups, as they exert their influence on cells and on the human body, so researchers must map out their connections to understand their functions, Coulombe said.

To chart this, researchers select a , mark it or tag it, then yank it from its cell along with its "partners," after which it can be identified by .

Studying certain proteins that we already knew to be involved in , for example, allowed the discovery in the same grouping of a new protein responsible for a specific form of the disease -- research which is key to finding the right treatments one day.

While we may already know the culprit gene, it is impossible at the moment to modify the DNA in all . On the other hand, we can have an effect on the proteins with the right chemical molecule, the biologist explained.

A protein can become "malicious" because of a "bad" in its , an evolution could be the result of something else, such as modification by an enzyme, in what is called an "epigenetic" event.

Charting the interactions of all of the body's 21,000 proteins is an immense task. Benoit Coulombe said laboratories currently use their own technologies to do so, but eventually will have to standardize their procedures to obtain comparable results.

The "I Cubed" program involves for now American, Austrian, Canadian, Swiss and German laboratories. Its steering committee has already started to standardize their procedures. Each group of researchers conducts the same experiments with 30 proteins and then they compare the results.

"For a complete map (of protein interactions), the human interactome, we will need 100 million dollars, five to 10 laboratories and five years of work," said Coulombe, whose team is primarily interested in cancer and neuromuscular diseases.

"We have to move step by step," but the genome sequencing "formidably accelerated" the scientific effort, he said.

"Genomic specialists are interested in genes, medical doctors in diseases, our research fills a void between these two," he added. They may also someday discover drugs for use against "bad proteins."

Related Stories

Recommended for you

Maternal diet may program child for disease risk, but better nutrition later can change that

October 20, 2017
Research has shown that a mother's diet during pregnancy, particularly one that is high-fat, may program her baby for future risk of certain diseases such as diabetes. A new study from nutrition researchers at the University ...

New gene editing approach for alpha-1 antitrypsin deficiency shows promise

October 20, 2017
A new study by scientists at UMass Medical School shows that using a technique called "nuclease-free" gene editing to correct cells with the mutation that causes a rare liver disease leads to repopulation of the diseased ...

Researchers find evidence of DNA damage in veterans with Gulf War illness

October 19, 2017
Researchers say they have found the "first direct biological evidence" of damage in veterans with Gulf War illness to DNA within cellular structures that produce energy in the body.

Researchers drill down into gene behind frontotemporal lobar degeneration

October 19, 2017
Seven years ago, Penn Medicine researchers showed that mutations in the TMEM106B gene significantly increased a person's risk of frontotemporal lobar degeneration (FTLD), the second most common cause of dementia in those ...

New clues to treat Alagille syndrome from zebrafish

October 18, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies potential new therapeutic avenues for patients with Alagille syndrome. The discovery, published in Nature Communications, ...

Genetic variants associated with obsessive-compulsive disorder identified

October 18, 2017
(Medical Xpress)—An international team of researchers has found evidence of four genes that can be linked to obsessive-compulsive disorder (OCD). In their paper published in the journal Nature Communications, the group ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.